التفاصيل البيبلوغرافية
| العنوان: |
Germline- and Somatic-Inactivating FLCN Variants in Parathyroid Cancer and Atypical Parathyroid Tumors. |
| المؤلفون: |
Jha, Smita, Welch, James, Tora, Rana, Lack, Justin, Warner, Andrew, del Rivero, Jaydira, Sadowski, Samira M., Nilubol, Naris, Schmidt, Laura S., Linehan, W. Marston, Weinstein, Lee S., Simonds, William F., Agarwal, Sunita K. |
| المصدر: |
Journal of Clinical Endocrinology & Metabolism; Oct2023, Vol. 108 Issue 10, p2686-2698, 13p |
| مصطلحات موضوعية: |
GERM cells, PARATHYROID gland cancer, HYPERCALCEMIA |
| مستخلص: |
Context: Parathyroid cancer (PC) is a rare endocrine neoplasm with high mortality. While surgery is the treatment for patients with the disease, recurrence rates are high, and patients usually succumb to severe hypercalcemia. There is no effective systemic therapy for the disease. Objective: To investigate for novel genes causing parathyroid cancer. Methods: We analyzed the germline DNA of 17 patients with “sporadic” PC and 3 with atypical parathyroid tumors (APTs) who did not have germline CDC73 or MEN1 pathogenic variants. Sequencing of available tumor tissue from 14 patients with PC and 2 with APT was also performed (including 2 patients with no available germline DNA). In addition, sporadic parathyroid adenomas from 74 patients were analyzed for FLCN variants. Results: We identified germline FLCN variants in 3 unrelated patients with PC. The 2 frameshift variants have been described in patients with Birt-Hogg-Dubé (BHD) syndrome, while the pathogenicity of the missense variant c.124G > C (p.G42R) has not been definitively established. Functional analysis of the missense variant showed a potential effect on posttranslational modification. All 3 patients with germline FLCN variants were noted to have renal cysts and 2 had lung cysts, features associated with BHD syndrome. Somatic FLCN variants were identified in tumors from 2 (1 APT) of 16 patients with PC/APT and in none of the 74 sporadic parathyroid adenomas. No second hits in FLCN were noted on sequencing; however, loss of heterozygosity at the locus was demonstrated in 2 of 3 patients with the identified germline FLCN variant. Conclusion: The finding of FLCN variants associated with PC may provide the foundation for the development of therapy for this malignancy. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Clinical Endocrinology & Metabolism is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |